DiGeorge Syndrome (22q11.2 deletion)

Overview and management of chromosomal disorder.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
GeneticsPaediatricsImmunology

Clinical Guidelines

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease
Local
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Local
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome)
Local
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome)
Local
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome) and Other Congenital Thymic Deficiency Disorders
Local
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome) and Other Congenital Thymic Deficiency Disorders
Local
Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226
Local
Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226
Local